FDA panel to discuss emergency use authorization for Merck COVID-19 pill
November 29, 2021 at 14:03 PM EST
Representatives from Merck will meet before advisers to the Food and Drug Administration on Tuesday to discuss emergency use authorization for the company's experimental COVID-19 pill.
